Jahrgang 5 (2021), Ausgabe 2
Complete issue
Editorial
Editorial
Seite 69 - 70
Articles
‘No-one is Safe Until Everyone is Safe’ – Patent Waiver, Compulsory Licensing and COVID-19 open-access
Seite 71 - 91
Reports
Case Notes
Sponsoring a Clinical Trial: Pharmaceutical Companies’ Liability under the Scrutiny of the Italian Supreme Court
Seite 98 - 101
Does an Initially Authorised Combination Medicinal Product and a Later Authorised Single Component of that Combination Belong to the Same Global Marketing Authorization? - The Tecfidera® Judgment of the General Court in Case T-611/18
Seite 102 - 105
Jurisdiction
Jurisdiction
Seite 106
Legislation
New EU Pharmaceutical Law and Policy
Seite 107